Press Releases and Multimedia Coverage

The Good Men Project
June 20, 2025
Blood Tests, CT Scan Risks, and Saving Lives

GenomeWeb
May 29, 2025
Johns Hopkins Researchers Develop Fragmentomic Test for Pancreatic Cancer Treatment Response

25 News Now
May 15, 2025
OSF HealthCare: Lung Cancer Screenings

San Francisco Business Times
May 15, 2025
How DELFI Diagnostics plans to make liquid biopsies more accessible

San Francisco Business Times
May 12, 2025
San Francisco Business Times Influential Women: Amoolya Singh, DELFI Diagnostics

Becker's Healthcare Podcast
April 27, 2025
How OSF Is Transforming Lung Cancer Screening with Innovative Blood Testing: Insights from Dr. Mark Meeker

Congressman Vern Buchanan
February 19, 2025
Buchanan Introduces Bills to Expand Access to Telehealth and Critical Lung Cancer Screenings

Mendelspod
February 6, 2025
Early Detection for Lung Cancer with Susan Tousi, DELFI Diagnostics

Channel 11 News
January 27, 2025
Allegheny Health Network Pilot Program Screens Lung Cancer Risk Through Blood Test

Medical Frontiers
January 6, 2025
Voice of Pittsburgh Interview with Dr. Ali Zaidi about FirstLook Lung

Observer-Reporter
December 13, 2024
Could a blood test detect lung cancer?

25 News Now
November 21, 2024
OSF HealthCare First Look Screenings

Pittsburgh Magazine
November 18, 2024
This Blood Test Can Help to Detect Whether or Not You Have Lung Cancer

Meeting You Where You're At Podcast
November 14, 2024
Episode 98: Susan Tousi - Stories from hlth.2024

Medical Laboratory Observer (MLO)
November 8, 2024
Peter Bach, MD, Chief Medical Officer of DELFI Diagnostics discusses blood test for lung cancer detection

MedCity News
November 3, 2024
Earlier Detection and Treatment are Essential for Meeting VBC Goals

The Doctor Podcast
November 1, 2024
Lung Cancer Screening Advances with Peter Bach, M.D.

Illumina Ventures
October 29, 2024
Spotlight on Susan Tousi – CEO DELFI Diagnostics

GenomeWeb
October 29, 2024
DELFI Diagnostics: Robert Guigley

Radiology Business
October 23, 2024
RadNet, American Lung Association launch ‘revolutionary’ cancer screening program

Biospace
October 22, 2024
DELFI Diagnostics Study on Cancer Treatment Monitoring Using Fragmentomes Featured in Nature Communications

360 Dx
August 26, 2024
DELFI Diagnostics: Thomas Russo

Precision Medicine Online
June 21, 2024
Delfi, Indigenous Pact Using Blood Test to Improve Lung Cancer Early Detection in Native Communities

Yahoo Finance
June 7, 2024
Johns Hopkins announces new blood test for early lung cancer detection

Stat
June 3, 2024
Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Los Angeles Daily News
May 31, 2024
City of Hope’s new blood test for lung cancer will mean more early detections

Chicago Tribune
May 10, 2024
A blood test to help detect lung cancer? New test offered at OSF Healthcare part of trend in medicine

The White House
May 1, 2024
FACT SHEET: As Part of the Inaugural National Cancer Prevention and Early Detection Month, Biden Cancer Moonshot Announces New Actions to Strengthen Preventive Cancer Care and Expand Accessibility of Cancer Screenings

OSF Healthcare Accelerated Podcast
April 23, 2024
Episode 31 - Take a Deep Breath Interview with Dr. Mark Meeker and Susan Tousi, CEO of DELFI Diagnostics

Washington Post
April 16, 2024
A blood test to detect cancer? Some patients are using them already

Precision Medicine Online
April 10, 2024
Delfi Diagnostics' Liquid Biopsy Technology Shows Promise for Ovarian Cancer Screening

US News & World Report
April 10, 2024
AI May Bring a Better Blood Test for Ovarian Cancer

GenomeWeb
April 2, 2024
City of Hope and DELFI Diagnostics announce collaboration to improve lung cancer screening rates in underserved areas of Los Angeles

GenomeWeb
March 15, 2024
Johns Hopkins Team Debuts New Method for Genome-Wide Detection of Cancer-Linked Repeat Sequences

Medium
February 17, 2024
Victor Velculescu, DELFI Diagnostics — Founder Story

Pharmexec
February 1, 2024
DELFI Diagnostics Launches Assay That May Improve Monitoring of Cancer Treatment Response

FierceBiotech
February 1, 2024
Delfi launches cancer-monitoring blood test alongside Immunocore collab

MedTech Dive
January 9, 2024
Susan Tousi leaves Illumina to become CEO of liquid biopsy firm Delfi

Baltimore Business Journal
January 5, 2024
Baltimore biotech backed by more than $300M in funding names new CEO

BNN Breaking
January 4, 2024
Susan Tousi, Illumina CCO, to Helm Delfi Diagnostics as New CEO

STAT
January 4, 2024
Illumina chief commercial officer leaves to lead liquid biopsy startup Delfi

Endpoints
January 4, 2024
Updated: Delfi Diagnostics hires Illumina’s chief commercial officer as next CEO

The Cancer Letter
November 17, 2023
Liquid biopsy cancer screening: We’ll need more than one size to fit all

MedTech Strategist
November 14, 2023
Can Delfi Diagnostics Fragmentomics be the key to detecting cancer early?

The Cancer Letter
October 13, 2023
Delfi Diagnostics Commercializes Blood Test for Lung Cancer Screening

Medical Device Network
October 10, 2023
DELFI Diagnostics introduces FirstLook Lung blood test

STAT
October 10, 2023
The Readout: Want a biotech buyout? Target cancer

MedTech Dive
October 9, 2023
Delfi launches lung cancer blood test based on DNA fragmentation

FierceBiotech
October 9, 2023
Delfi Diagnostics launches blood-based lung cancer screening test

STAT
October 9, 2023
Delfi launches its blood test to screen for lung cancer – and reveals challenges for liquid biopsies

BioTech TV
October 9, 2023
Delfi Diagnostics' team on launching the FirstLook Lung cancer blood screening test at #HLTH2023

360DX
September 26, 2023
BioAffinity Aims to Make Lung Cancer Test Available Nationally Following Pathology Lab Acquisition

STAT News
September 7, 2023
What a viral study criticizing cancer screening gets very, very wrong

GenomeWeb
August 22, 2023
DELFI Diagnostics Boost Lung Cancer Detection Power with Addition of Mutation Profiles DELFI Diagnostics Boost Lung Cancer Detection Power with Addition of Mutation Profiles

NCI Cancer Currents Blog
May 15, 2023
Can the New “Omics” on the Block Find Liver Cancer in Blood?

Baltimore Business Journal
May 12, 2023
Raising Baltimore’s Capital

STAT News
May 4, 2023
‘Are we better off with the information?’: Experts spar over the benefits of liquid biopsy to catch cancer

The Baltimore Sun
January 29, 2023
Baltimore researchers say AI could help reduce disparities, improve access in health care

Baltimore Business Journal
October 7, 2022
Leaders in Health Care 2022: Dr. Victor Velculescu, Delfi Diagnostics

Business Insider
September 6, 2022
21 Most Promising Health Tech Startups According to VCs 2022

San Francisco Business Times
August 30, 2022
Early-cancer detection company takes on billion-dollar competitors

Wall Street Journal
July 18, 2022
Delfi Diagnostics Gathers $225M for Cancer Blood Tests

GenomeWeb
May 17, 2022
Delfi Diagnostics, Memorial Sloan Kettering Partner to Advance Cancer Screening Technology

Precision Oncology News
May 9, 2022
Delfi Diagnostics Begins Second, Larger Prospective Lung Cancer Screening Trial

Fierce Biotech
March 7, 2022
Fierce Medtech’s 2021 Fierce 15

Fierce Biotech
August 20, 2021
Delfi Diagnostics’ AI-based blood test detects 80% of early-stage lung cancer cases, study finds

Stat News
June 23, 2021
Peter Bach, Industry Critic, Joins Company Aiming to Make Blood Tests to Detect Cancer

GenomeWeb
March 31, 2021
Delfi Diagnostics Starts Prospective Lung Cancer Screening Trial

FierceBiotech
January 13, 2021
Delfi Diagnostics Raises $100M for a New Approach to Screening Blood for Cancer

GenomeWeb
February 5, 2020
Methylation, Fragmentation Analyses Remain at Forefront of Early Detection Liquid Biopsy Development